Role of Oral Citicoline in Treatment of Adolescent Amblyopia

Published

2023-07-04

Keywords:

.rrdbt.-Js.amb,yop.a oc('.rs,oa

Dimensions Badge

Authors

  • Vibha Singh .
  • Mayank Kumar Srivastava .
  • Aparajita Chaulhary .
  • Jagriti Rana .
  • S.p Singh .

Abstract

Aim: To compare efficacy of Citicoline to occlusion and near activity exercise in amblyopia
management in adolescent age group.
Material and Methods: We included 79 eligible patients of age group 10 19 years for
study. Consent was taken from each of patents. All candidates underwent full
ophthalmological examination and were prescribed the best corrected spectacles. They were
divided in three groups (A, B, C) using randomization chart. Group A received full time occlusion, Group B received full time occlusion and near activity exercises and Group c received full time occlusion and Citicoline 500mg BD for three months.They were followed up four weekly up to 24 weeks.
Results: During follow up 9 patients were lost to follow up. Out of 70 patients who completed stud, 36 (51.43%) showed improvement in their vision for distance. we measured this improvement in lines on Snellen’s Chart. No improvement was found in 14 patients (58%) in Group A, 15 patients (60%) n Group B and 5 patients (23.81%) in Group C. Of the respondents, groups A, B and C constituted 41.67%, 40% and
76%.2% respectively. The difference among the three groups was statistically significant (p value-0.024 chi-square test).

Conclusion: Oral Citicorine is a new and effective modality for amblyopia management and chance of improvement in visual acuity is better than other treatment modalities.

How to Cite

1.
Singh V, Srivastava MK, Chaulhary A, Rana J, Singh S. Role of Oral Citicoline in Treatment of Adolescent Amblyopia. UPJO [Internet]. 2023 Jul. 4 [cited 2025 Feb. 23];4(01):9-16. Available from: https://upjo.org/index.php/upjo/article/view/303

Downloads

Download data is not yet available.